Entity
  • Pan Cancer T

    Created in 2020
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    1,230
  • Activities

  • Technologies

  • Entity types

  • Location

    Marconistraat 16, 3029 AK Rotterdam, Netherlands

    Rotterdam

    Netherlands

  • Employees

    Scale: 2-10

    Estimated: 9

  • Engaged corporates

    1
    1 0
  • Added in Motherbase

    3 months, 2 weeks ago
Description
  • Value proposition

    Pan Cancer T is a biotechnology company developing T cell receptor (TCR) T-cell therapy for solid tumors.

    Pan Cancer T is a biotechnology spin-out (Erasmus MC, Rotterdam) focussed on the discovery and development of T cell receptor (TCR) T cell therapies. We exploit the 20 years of pioneering in adoptive T cell therapy as a springboard to breakthrough treatment of solid tumors.

    Pan Cancer T develops natural affinity TCR T cell therapies towards unique and proprietary intracellular targets expressed by multiple solid tumors, and make T cell therapy maximally accessible despite the tumor micro-environment challenges.

  • About - Pan Cancer T

    Pan Cancer T is an immunotherapy company developing next-generation TCR-T cell therapies for solid cancer.

  • https://pancancer-t.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Cap Digital
Cap Digital
Public business cluster, French Cluster, IT Services and IT Consulting
Cap Digital
Public business cluster, French Cluster, IT Services and IT Consulting
Other

15 Jan 2024


Similar entities
Loading...
Loading...
Social network dynamics